NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MygeA.00039.a: Methionine aminopeptidase (MG_172)

Target Characteristics

from organism: Mycoplasma genitalium ATCC 33530 / G-37 / NCTC 10195
most recent status: target approved
center reference id: MygeA.00039.a
is community request: False
associated disease:
NIH risk group: unclassified
is select agent: False
NIH priority
pathogens category:
C

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Molecular models

Method Results
comparative modelling Robetta_10491

External Resources

Resource Reference ID
PATRIC ID: fig|243273.25.peg.194
UniProt: P47418

Enzyme & Pathway Information

Pathway Pathway ID EC Number
Arg/N-end rule pathway (eukaryotic) PWY-7799 3.4.11.18
Ac/N-end rule pathway PWY-7800 3.4.11.18

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MIYLKSANEV AGIKKACAIF KAVKAYFTIE KLLGKKLVTI DRLIKQFIEQ KQAKCAFHGY LGFPGFNCLS LNQTVIHGVA DQTVFKDSDK LTLDIGIDYH GYLCDAAFTL LGNKADPKAV KLLNDVEQAF SKVIEPELFV NNPIGNLSNA IQTYFENKGY FLVKEFGGHG CGIKIHEDPL ILNWGEKNQG VRLQEGMVIC IEPMVMTDSS EITMAANNWN VLTLKSKFNC HVEQMYHITN NGFECLTN

NT Sequence
ATGATCTATC TCAAATCTGC AAATGAAGTT GCAGGGATTA AAAAAGCATG TGCAATCTTC AAAGCAGTTA AGGCATATTT TACAATTGAA AAGTTACTTG GCAAAAAGTT GGTTACCATT GATCGTTTAA TCAAACAATT CATTGAACAA AAACAAGCTA AATGTGCGTT TCATGGTTAT CTAGGTTTCC CTGGTTTTAA CTGTCTATCG TTAAACCAAA CGGTTATCCA TGGAGTTGCC GATCAAACTG TTTTTAAAGA TAGTGATAAA CTAACGCTTG ACATTGGGAT AGACTATCAT GGTTATCTTT GTGATGCAGC TTTCACTTTA CTTGGTAATA AAGCTGATCC AAAGGCAGTA AAACTGTTAA ATGATGTTGA ACAAGCATTT AGTAAGGTAA TTGAACCTGA GCTATTTGTT AACAATCCGA TTGGTAATTT ATCCAATGCG ATCCAAACTT ACTTTGAAAA CAAGGGCTAT TTTCTTGTCA AAGAGTTTGG GGGTCATGGT TGTGGGATTA AGATCCATGA AGATCCTTTA ATCTTAAACT GGGGAGAGAA AAACCAGGGC GTTAGGTTAC AAGAGGGGAT GGTAATCTGT ATTGAACCGA TGGTTATGAC TGATAGTAGT GAGATAACAA TGGCAGCTAA CAACTGGAAT GTACTAACTT TAAAGAGTAA GTTTAACTGT CATGTGGAAC AGATGTATCA CATCACAAAC AACGGCTTTG AATGTTTAAC TAAC

© 2020 Seattle Children's Research Institute. All rights reserved.